West Pharmaceutical Services Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied decreased by 11.6% to $3.80M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
A growing backlog indicates strong future demand and revenue visibility, while a shrinking backlog may signal a slowdown in new contract wins.
This represents the total transaction price allocated to performance obligations that are unsatisfied or partially unsat...
Highly relevant for companies with long-term government or industrial contracts; a key indicator of competitive market position.
other_revenue_remaining_performance_obligation| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $3.10M | $2.80M | $4.30M | $3.80M |
| QoQ Change | — | -9.7% | +53.6% | -11.6% |
| YoY Change | — | — | — | +22.6% |